Table 3
Documentation of After-care Instructions
| % of Patients | Difference in % (95% CI) | ||||
| Phase 1 | Phase 2 | Phase 3 | Phases 1 vs. 2 | Phases 1 vs. 3 | |
| Antipyretics* | 66 | 85 | 58 | 20 (11 to 28) | −8 (−20 to 5) |
| Antipyretic dosing* | 44 | 78 | 20 | 35 (26 to 44) | −24 (−34 to −13) |
| Lethargy* | 28 | 77 | 37 | 48 (39 to 58) | 9 (−5 to 22) |
| Not eating/drinking* | 38 | 78 | 67 | 41 (30 to 51) | 30 (16 to 43) |
| No urine output* | 8 | 69 | 7 | 61 (53 to 70) | 0 (−6 to 6) |
| Fever past 2 days* | 52 | 82 | 57 | 30 (21 to 38) | 5 (−9 to 18) |
| Antibiotic name† | 81 | 89 | 78 | 9 (0 to 18) | −3 (−19 to 13) |
| Antibiotic dosing† | 54 | 80 | 31 | 26 (14 to 37) | −24 (−43 to −5) |
| Antibiotic reasoning/hints/side effects† | 4 | 65 | 6 | 61 (51 to 71) | 2 (−6 to 10) |
| Oral rehydration‡ | 58 | 93 | 72 | 35 (26 to 44) | 14 (−3 to 30) |
| Overall % (95% CI) | 48 (45 to 51) | 81 (76 to 86) | 50 (48 to 52) | 33 (28 to 38) | 2 (−2 to 5) |
